| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 3,887,000 | 6,049,000 | 2,399,000 | 2,262,000 | | Cost of Revenue | 474,000 | 546,000 | 333,000 | 340,000 | | | Gross Profit | 3,413,000 | 5,503,000 | 2,066,000 | 1,922,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,658,000 | 2,328,000 | 1,131,000 | 1,142,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 168,000 | 2,103,000 | 1,162,000 | 224,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 587,000 | 1,072,000 | (227,000) | 556,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 587,000 | 1,072,000 | (227,000) | 556,000 | | Interest Expense | 345,000 | 409,000 | 218,000 | 234,000 | | Income Before Tax | 242,000 | 663,000 | (445,000) | 322,000 | | Income Tax Expense | 35,000 | 133,000 | (197,000) | 74,000 | | Minority Interest | (13,000) |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 194,000 | 530,000 | (248,000) | 248,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 194,000 | 530,000 | (248,000) | 248,000 | | Preferred Stock And Other Adjustments | (129,000) | (70,000) |
-
|
-
| | | Net Income Applicable To Common Shares | $65,000 | $460,000 | ($248,000) | $248,000 |
|
0.20% Nasdaq 
0.14%
Income Statement
